Contract with Customer, Liability, Current in USD of ELITE PHARMACEUTICALS INC /NV/ from Q1 2021 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
Summary
ELITE PHARMACEUTICALS INC /NV/ quarterly Contract with Customer, Liability, Current history and change rate from Q1 2021 to Q2 2025.
  • ELITE PHARMACEUTICALS INC /NV/ Contract with Customer, Liability, Current for the quarter ending 30 Jun 2025 was $2.22K, a 83.3% decline year-over-year.
Contract with Customer, Liability, Current, Quarterly (USD)
Contract with Customer, Liability, Current, YoY Quarterly Change (%)

ELITE PHARMACEUTICALS INC /NV/ Quarterly Contract with Customer, Liability, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 $2.22K -$11.1K -83.3% 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 $5.56K -$7.78K -58.3% 31 Mar 2025 10-Q 14 Nov 2025
Q4 2024 $8.89K -$4.44K -33.3% 31 Dec 2024 10-Q 13 Feb 2025
Q3 2024 $12.2K -$1.11K -8.33% 30 Sep 2024 10-Q 14 Nov 2024
Q2 2024 $13.3K $0 0% 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 $13.3K $0 0% 31 Mar 2024 10-K 30 Jun 2025
Q4 2023 $13.3K $0 0% 31 Dec 2023 10-Q 14 Feb 2024
Q3 2023 $13.3K $0 0% 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 $13.3K $0 0% 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 $13.3K $0 0% 31 Mar 2023 10-K 01 Jul 2024
Q4 2022 $13.3K $0 0% 31 Dec 2022 10-Q 14 Feb 2023
Q3 2022 $13.3K 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 $13.3K 30 Jun 2022 10-Q 15 Aug 2022
Q1 2022 $13.3K $0 0% 31 Mar 2022 10-K 29 Jun 2023
Q4 2021 $13.3K 31 Dec 2021 10-Q 14 Feb 2022
Q1 2021 $13.3K 31 Mar 2021 10-K 29 Jun 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.